Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recognizing drug-induced liver injury: current problems, possible solutions.

William M Lee1, John R Senior

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas 75390-9151, USA.

Toxicologic Pathology
|April 5, 2005
PubMed
Summary

Establishing drug-induced liver injury (DILI) causality and incidence are major challenges. New prospective studies are needed to accurately determine DILI

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of viral and host factors in determining the outcome of HBV-associated acute liver failure.

Journal of translational medicine·2026
Same author

Comparison of LDH activity and LDH-M to predict death in patients with acetaminophen-induced acute liver failure.

EXCLI journal·2026
Same author

Identification of Genetic Risk Factors Associated With Herbal and Dietary Supplement-Induced Acute Liver Failure Using Whole Exome Sequencing Analysis.

Gastro hep advances·2025
Same author

Autoantibodies neutralizing type I IFNs in patients with fulminant herpes simplex virus hepatitis.

The Journal of experimental medicine·2025
Same author

The DILI-Inpt Prognostic Score to Identify Hospitalized Idiosyncratic DILI Patients at Risk for Adverse Outcomes.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
Same author

The endothelial growth factor angiopoietin-2 is an accurate prognostic biomarker in patients with acetaminophen-induced acute liver failure.

Toxicological sciences : an official journal of the Society of Toxicology·2025

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Drug-induced liver injury (DILI) presents significant diagnostic and epidemiological challenges.
  • Current understanding is hampered by difficulties in establishing causality and determining true incidence.
  • Elucidating the mechanisms of liver cell injury remains a complex, long-term goal.

Purpose of the Study:

  • To address the critical issues of causality attribution and incidence determination in DILI.
  • To highlight the limitations of current methods for diagnosing and quantifying DILI.
  • To advocate for improved methodologies in DILI research.

Main Methods:

  • Focus on analyzing temporal relationships between drug exposure and illness.
  • Emphasize the necessity of excluding alternative causes for liver disease.

Related Experiment Videos

  • Critique current methods including clinical trials, adverse event reports, and retrospective studies.

    • Main Results:

    • No pathognomonic indicators exist for DILI, making diagnosis challenging even with liver biopsy.
    • Current methods are inadequate for accurately determining DILI incidence and risk factors.
    • Prospective safety studies are essential for reliable data collection.

    Conclusions:

    • Reliable causality assessment and incidence determination for DILI require enhanced research approaches.
    • Prospective studies are crucial for identifying DILI risk factors and collecting biological samples.
    • Further research is needed to fully understand the mechanisms of drug-induced hepatotoxicity.